Immune to Cancer: The CRI Blog
-
<strong><u>AACR 2023 Recap: CRI Scientists Tackle the Frontiers of Cancer Immunotherapy</u></strong>
More than any conference yet, the 2023 annual meeting of the American Association for Cancer Research (AACR… -
<strong>E. John Wherry, PhD, Receives 2023 AACR-CRI Lloyd J. Old Award in Cancer Immunology</strong>
E. John Wherry, PhD — the director of the Institute for Immunology, chair of the Department of… -
AACR 2023 Preview: Advancing the Frontiers of Cancer Science and Medicine
From April 14-19, the 2023 AACR annual meeting highlights a broad scope of immunotherapy breakthroughs, including cell… -
<strong>A Conversation with CRI ImmunoAdvocate Karen Peterson</strong>
Karen Peterson shares her journey from an immunotherapy clinical trial to patient advocate working to improve clinical… -
Love in the Lab: Valentine’s Day with the Doctors Delgoffe
CRI celebrates Valentine’s Day with immunologists Abby and Greg Delgoffe At first glance, one might not link… -
The IO Clinical Trial Gap in the Black Patient Population: It’s Time to Sound the Alarm
In 2017, I was diagnosed with stage four triple-negative breast cancer (TNBC), one of the most aggressive… -
Celebrating Seven Decades of CRI Discovery in Cancer Immunotherapy
On January 27, 1953, the Cancer Research Institute’s founders, Helen Coley Nauts and Oliver R. Grace Sr.,… -
Five Cancer Research Institute Scientists Recognized with Career Awards by The American Association of Immunologists
Five CRI-supported scientists were honored with AAI Career Awards Coinciding with the 70th anniversary of the founding… -
5 Things Patients, Caregivers, and Families Need to Know About Cancer
Our CEO speaks with Medium/Authority Magazine about cancer, immunotherapy, and how she became CEO of the world’s…
Join CRI in Shaping the Future of Immunotherapy
Support the pioneering work of CRI in advancing immunotherapy.